STAGG ROBERT (SVP, Clinical R&D) sold 2.2% of their position (927.00 shares) of ONCOMED PHARMACEUTICALS INC on the open market
Open‑market sale worth $1.9K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 10/11/2018ACC: 0001567619-18-004058
Officer· SVP, Clinical R&D
Since Oct 2018
-927.00
Net shares
Net seller
$1.9K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
927.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−927.00
Price / share
$2.01
Trade value
$1.86K
% of position
2.2%
10/10/2018
41.60K→40.67K
Total
Net shares
−927.00
Net value
-$1.86K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/10/2018 | S · Sale | −927.00 | $2.01 | $1.86K | 2.2% | 41.60K | 40.67K |
| Total | −927.00 | -$1.86K | ||||||
Derivative Transactions0
No derivative transactions reported